Alzheimers would be a stupid target for ANP !
A lot of money, a lot of time, large trials and a biotech graveyard with 99% failure rate - leave that stuff to big pharma with money to burn.
ANP’s best to stick with rare diseases which i think they will - as is we still need to finding the funding for the IIB trial.
Alzheimers would be a stupid target for ANP ! A lot of money, a...
-
- There are more pages in this discussion • 557 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
0.8¢ |
Change
-0.001(5.88%) |
Mkt cap ! $8.699M | |||
| Open | High | Low | Value | Volume |
| 0.9¢ | 0.9¢ | 0.8¢ | $16.64K | 2.010M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 24 | 6525662 | 0.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.9¢ | 1987416 | 4 |
View Market Depth
| Last trade - 15.25pm 18/07/2025 (20 minute delay) ? |
| PER (ASX) Chart |